Last updated: May 7, 2024
Sponsor: United States Naval Medical Center, Portsmouth
Overall Status: Terminated
Phase
N/A
Condition
N/ATreatment
Daily abdominal x-rays
Ambulation regimen
pedometers
Clinical Study ID
NCT01241123
CIP# 10-0061
Ages > 17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subject patients are those who will undergo colorectal surgeries at NMCP. Colorectalsurgery is defined as any surgery involving the gastrointestinal tract from theileocecal valve to the dentate line and includes all laparoscopic approaches. Thissurgery includes, but is not limited to:
- Ileocecetomy
- Partial colectomy (including right, left, and sigmoid colectomies)
- Hartmann procedure
- Total abdominal colectomy
- Proctocolectomy
- Colostomy formation or takedown
- Low anterior resection
- Abdominoperineal resection
Exclusion
Exclusion Criteria:
- Reasons for subject exclusion are non-ambulatory conditions are conditions whereby asubject cannot walk or move from place to place. Examples of non-ambulatory conditionsinclude but are not limited to: severe vasculopathy with limiting claudication (legpain when ambulating due to poor blood flow) of less than 100 meters, all wheelchairbound conditions (anatomically missing both legs without adequate prosthesis, severelylimiting pulmonary disease, neurologic disorders - Amyotrophic Lateral Sclerosis,severe multiple sclerosis, paraplegia), fractured leg bones requiring temporary and/orpermanent use of a walking aid or any congenital disorders limiting ambulation (osteogenesis imperfecta, muscular dystrophy, cerebral palsy). Any patient who takesAlvimopan (Entereg ®) will be excluded or terminated from the study. Alvimopan is anFDA-approved drug that accelerates bowel motility and is used to prevent and/or treatpost-operative ileus. In addition, patients with underlying gastrointestinal motilityissues, gastroparesis, chronic constipation, etc or who may have complications who maynot be able to ambulate during the hospital course (i.e. prolonged intubatedpostoperatively) will be excluded as well. Pregnant women will also be excluded fromthe study.
Study Design
Total Participants: 30
Treatment Group(s): 4
Primary Treatment: Daily abdominal x-rays
Phase:
Study Start date:
March 31, 2010
Estimated Completion Date:
September 10, 2014
Connect with a study center
Naval Medical Center Portsmouth
Portsmouth, Virginia 23708
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.